Cuspa Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Crowdfunding
- Investors
-
3
Cuspa General Information
Description
Operator of a medical device company intended to address valve insufficiency. The company's artificial cusp is attached to the native aortic cusp using a nitinol grasper that keeps the valve opening at its original size and prevents cusp-to-cusp separation, enabling patients to undergo a minimally invasive transcatheter treatment.
Contact Information
Website
www.cuspamedical.comCorporate Office
- Wadi El Haj 13
- Nazareth 17111
- Israel
Corporate Office
- Wadi El Haj 13
- Nazareth 17111
- Israel
Cuspa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Equity Crowdfunding | 02-Jan-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 30-Mar-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Mar-2020 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cuspa Comparisons
Industry
Financing
Details
Cuspa Competitors (1)
One of Cuspa’s competitors is JenaValve Technology, a Private Equity-Backed company based in Irvine, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| JenaValve Technology | Private Equity-Backed | Irvine, CA |
Cuspa Patents
Cuspa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025233944-A1 | Transcatheter artificial cusp for valve insufficiency | Pending | 08-May-2024 | ||
| EP-4440502-A1 | Transcatheter artificial cusp for valve insufficiency | Pending | 02-Dec-2021 | ||
| EP-4440502-A4 | Transcatheter artificial cusp for valve insufficiency | Pending | 02-Dec-2021 | ||
| US-20250025301-A1 | Transcatheter artificial cusp for valve insufficiency | Pending | 02-Dec-2021 | ||
| WO-2023100176-A1 | Transcatheter artificial cusp for valve insufficiency | Inactive | 02-Dec-2021 | A61F2/246 |
Cuspa Signals
Cuspa Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Israel MedicUp | Venture Capital | Minority | ||
| MassChallenge | Accelerator/Incubator | |||
| NGT HealthCare II | Venture Capital | Minority |
Cuspa FAQs
-
When was Cuspa founded?
Cuspa was founded in 2019.
-
Where is Cuspa headquartered?
Cuspa is headquartered in Nazareth, Israel.
-
What is the size of Cuspa?
Cuspa has 2 total employees.
-
What industry is Cuspa in?
Cuspa’s primary industry is Therapeutic Devices.
-
Is Cuspa a private or public company?
Cuspa is a Private company.
-
What is Cuspa’s current revenue?
The current revenue for Cuspa is .
-
Who are Cuspa’s investors?
Israel MedicUp, MassChallenge, and NGT HealthCare II have invested in Cuspa.
-
Who are Cuspa’s competitors?
JenaValve Technology is a competitor of Cuspa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process